The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression
Open accessAbstract
Histone modifications play a pivotal role in regulating transcription and other chromatin-associated processes. In yeast, histone H2B monoubiquitylation affects gene silencing. However, mammalian histone ubiquitylation remains poorly understood. We report that the Mdm2 oncoprotein, a RING domain E3 ubiquitin ligase known to ubiquitylate the p53 tumor suppressor protein, can interact directly with histones and promote in vitro monoubiquitylation of histones H2A and H2B. Moreover, Mdm2 induces H2B monoubiquitylation in vivo. Endogenous Mdm2 is tethered in vivo, presumably via p53, to chromatin comprising the p53-responsive p21(waf1) promoter, and Mdm2 overexpression enhances protein ubiquitylation in the vicinity of a p53 binding site within that promoter. Moreover, when recruited to a promoter in the absence of p53, Mdm2 can repress transcription dependently on its RING domain, suggesting that its E3 activity contributes to repression. Histone ubiquitylation may thus constitute a novel mechanism of transcriptional repression by Mdm2, possibly underlying some of its oncogenic activities.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mdm2 can transcriptionally inactivate some p53 target genes by direct ubiquitylation of histones.
“For example, Mdm2 can transcriptionally inactivate some p53 target genes by direct ubiquitylation of histones [109].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [109]
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · see citing works
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466 · see citing works
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · see citing works
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,177 · see citing works
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · see citing works
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949 · see citing works
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,447 · see citing works
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,231 · see citing works
Histone modifications in transcriptional regulation
Berger, S. L. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00279-4 · Cited by 1,222 · see citing works
Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast
Sun, Z., & Allis, C. D. (2002) · Nature · doi:10.1038/nature00883 · Cited by 1,076 · see citing works
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044 · see citing works
Rb targets histone H3 methylation and HP1 to promoters
Nielsen, S. J., Schneider, R., Bauer, U., Bannister, A. J., Morrison, A. J., O’Carroll, D., Firestein, R., Cleary, M. L., Jenuwein, T., Herrera, R. E., et al. (2001) · Nature · doi:10.1038/35087620 · Cited by 901 · see citing works
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
Flores, E. R., Tsai, K. Y., Crowley, D. G., Sengupta, S., Yang, A., McKeon, F., & Jacks, T. (2002) · Nature · doi:10.1038/416560a · Cited by 801 · see citing works
The p53–Mdm2 module and the ubiquitin system
Michael, D., & Oren, M. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00099-8 · Cited by 759 · see citing works
Self-citationHenry, K. W., Wyce, A., Lo, W.-S., Duggan, L. J., Emre, N. C. T., Kao, C.-F., Pillus, L., Shilatifard, A., Osley, M. A., & Berger, S. L. (2003) · Genes & Development · doi:10.1101/gad.1144003 · Cited by 714 · see citing works
Histone sumoylation is associated with transcriptional repression
Shiio, Y., & Eisenman, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735528100 · Cited by 704 · see citing works
Rad6-Dependent Ubiquitination of Histone H2B in Yeast
Robzyk, K., Recht, J., & Osley, M. A. (2000) · Science · doi:10.1126/science.287.5452.501 · Cited by 666 · see citing works
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570 · see citing works
Trans-histone regulatory pathway in chromatin
Briggs, S. D., Xiao, T., Sun, Z., Caldwell, J., Shabanowitz, J., Hunt, D. F., Allis, C. D., & Strahl, B. D. (2002) · Nature · doi:10.1038/nature00970 · Cited by 516 · see citing works
Dumaz, N., & Meek, D. W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7002 · Cited by 455 · see citing works
Transcriptional regulation by histone ubiquitination and deubiquitinationPreprint
Zhang, Y. (2003) · Genes & Development · doi:10.1101/gad.1156403 · Cited by 425 · see citing works
A revised picture of the E2F transcriptional network and RB function
Nolan-Stevaux, O., & Dyson, N. J. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00388-5 · Cited by 423 · see citing works
Phosphorylation of p53 Serine 15 Increases Interaction with CBP
Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R., & Brady, J. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33048 · Cited by 423 · see citing works
Roest, H. P., van Klaveren, J. W., de Wit, J., van Gurp, C. G., Koken, M. H. M., Vermey, M., van Roijen, J. H., Hoogerbrugge, J. W., Vreeburg, J. T. M., Baarends, W. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80154-3 · Cited by 396 · see citing works
Honda, R., & Yasuda, H. (2000) · Oncogene · doi:10.1038/sj.onc.1203464 · Cited by 376 · see citing works
Weinmann, A. S., & Farnham, P. (2002) · Methods · doi:10.1016/s1046-2023(02)00006-3 · Cited by 349 · see citing works
Kaeser, M., & Iggo, R. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.012283399 · Cited by 346 · see citing works
Deubiquitination of Histone H2B by a Yeast Acetyltransferase Complex Regulates Transcription
Daniel, J. A., Torok, M. S., Sun, Z., Schieltz, D. M., Allis, C. D., Yates, J. R., & Grant, P. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300494200 · Cited by 299 · see citing works
The p53 and Mdm2 families in cancer
Michael, D. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00264-7 · Cited by 288 · see citing works
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains
Mallery, D. L., Vandenberg, C. J., & Hiom, K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf691 · Cited by 280 · see citing works
Repression of p53-mediated transcription by MDM2: a dual mechanism
Thut, C. J., Goodrich, J. A., & Tjian, R. (1997) · Genes & Development · doi:10.1101/gad.11.15.1974 · Cited by 272 · see citing works
RB Regulates the Stability and the Apoptotic Function of p53 via MDM2
Hsieh, J.-K., Chan, F., O’Connor, D. J., Mittnacht, S., Zhong, S., & Lü, X. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80309-3 · Cited by 255 · see citing works
Regulation of Transcription Functions of the p53 Tumor Suppressor by the mdm-2 Oncogene
Chen, J., Lin, J., & Levine, A. J. (1995) · Molecular Medicine · doi:10.1007/bf03401562 · Cited by 214 · see citing works
Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein
Xia, Y., Pao, G. M., Chen, H.-W., Verma, I. M., & Hunter, T. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204591200 · Cited by 195 · see citing works
Kobet, E., Zeng, X., Zhu, Y., Keller, D., & Lu, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12547 · Cited by 193 · see citing works
Np95 Is a Histone-Binding Protein Endowed with Ubiquitin Ligase Activity
Citterio, E., Papait, R., Nicassio, F., Vecchi, M., Gomiero, P., Mantovani, R., Fiore, P. P. D., & Bonapace, I. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2526-2535.2004 · Cited by 191 · see citing works
Kinetics of p53 Binding to Promoter Sites In Vivo
Szak, S. T., Mays, D. J., & Pietenpol, J. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3375-3386.2001 · Cited by 178 · see citing works
Histone ubiquitination: a tagging tail unfolds?
Jason, L. J. M., Moore, S. C., Lewis, J. D., Lindsey, G. G., & Ausió, J. (2002) · BioEssays · doi:10.1002/bies.10038 · Cited by 164 · see citing works
The Mdm2 Oncoprotein Interacts with the Cell Fate Regulator Numb
Juven‐Gershon, T., Shifman, O., Unger, T., Elkeles, A., Haupt, Y., & Oren, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3974 · Cited by 136 · see citing works
Self-citationSpotswood, H. T., & Turner, B. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16547 · Cited by 124 · see citing works
The structure of ubiquitinated histone H2B.
Thorne, A. W., Sautière, P., Briand, G., & Crane‐Robinson, C. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04852.x · Cited by 115 · see citing works
Shekhar, M. P. V., Lyakhovich, A., Visscher, D. W., Heng, H. H., & Kondrat, N. (2002) · PubMed · Cited by 104 · see citing works
Daujat, S., NEEL, H., & PIETTE, J. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02369-1 · Cited by 97 · see citing works
Spotswood, H. T., & Turner, B. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216547 · Cited by 97 · see citing works
The X protein of hepatitis B virus coactivates potent activation domains
Haviv, I., Vaizel, D., & Shaul, Y. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.1079 · Cited by 93 · see citing works
The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
Argentini, M., Barboule, N., & Wasylyk, B. (2001) · Oncogene · doi:10.1038/sj.onc.1204241 · Cited by 90 · see citing works
MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation
Jin, Y., Zeng, S. X., Dai, M., Yang, X., & Lu, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204078200 · Cited by 86 · see citing works
Evolving intricacies and implications of E2F1 regulation
Mundle, S. D., & Saberwal, G. S. (2003) · The FASEB Journal · doi:10.1096/fj.02-0431rev · Cited by 84 · see citing works
MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest.
Mc, D.-P., Tocqué, B., & Wasylyk, B. (1995) · PubMed · Cited by 76 · see citing works
Promoter-specific p53-dependent histone acetylation following DNA damage
Kaeser, M. D., & Iggo, R. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207536 · Cited by 62 · see citing works
Mdm2: A Regulator of Cell Growth and Death
Alarcon-Vargas, D., Takahashi, S., & Ronai, Z. A. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)01001-7 · Cited by 57 · see citing works
Function and dysfunction of the human oncoprotein MDM2
Deb, S. P. (2002) · Frontiers in bioscience · doi:10.2741/a723 · Cited by 45 · see citing works
Function and dysfunction of the human oncoprotein MDM2
Deb, S. P. (2002) · Frontiers in bioscience · doi:10.2741/deb · Cited by 11 · see citing works
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · see citing works
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854 · see citing works
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · see citing works
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N. B.-C., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352 · see citing works
Self-citationShilatifard, A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051710-134100 · Cited by 1,091 · see citing works
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838 · see citing works
Histone ubiquitination: triggering gene activity.
Weake, V. M., & Workman, J. (2008) · Molecules and Cells · doi:10.1016/j.molcel.2008.02.014 · Cited by 742 · see citing works
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569 · see citing works
Monoubiquitination of Human Histone H2B: The Factors Involved and Their Roles in HOX Gene Regulation
Zhu, B., Zheng, Y., Pham, A.-D., Mandal, S. S., Erdjument‐Bromage, H., Tempst, P., & Reinberg, D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.09.025 · Cited by 532 · see citing works
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works
Zhou, W., Zhu, P., Wang, J., Pascual, G., Ohgi, K. A., Lozach, J., Glass, C. K., & Rosenfeld, M. G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.11.002 · Cited by 407 · see citing works
Minsky, N., Shema, E., Field, Y., Schuster, M., Segal, E., & Oren, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1712 · Cited by 390 · see citing works
Self-citationMdm2-mediated ubiquitylation: p53 and beyond
Marine, J.-C., & Lozano, G. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.68 · Cited by 354 · see citing works
Shema, E., Tirosh, I., Aylon, Y., Huang, J. L., Ye, C., Moskovits, N. B.-C., Raver-Shapira, N., Minsky, N., Pirngruber, J., Tarcic, G., et al. (2008) · Genes & Development · doi:10.1101/gad.1703008 · Cited by 288 · see citing works
Self-citationA positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidizationPreprint
Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H., & Oren, M. (2006) · Genes & Development · doi:10.1101/gad.1447006 · Cited by 284 · see citing works
Self-citationDisulfide-directed histone ubiquitylation reveals plasticity in hDot1L activation
Chatterjee, C., McGinty, R. K., Fierz, B., & Muir, T. W. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.315 · Cited by 249 · see citing works
Karagianni, P., Amazit, L., Qin, J., & Wong, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01598-07 · Cited by 249 · see citing works
Itahana, K., Mao, H., Jin, A., Itahana, Y., Clegg, H. V., Lindström, M. S., Bhat, K. P., Godfrey, V. L., Evan, G. I., & Zhang, Y. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.09.007 · Cited by 245 · see citing works
Surf the Post-translational Modification Network of p53 Regulation
Gu, B., & Zhu, W. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4283 · Cited by 234 · see citing works
Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228 · see citing works
Shi, D., & Gu, W. J. (2012) · Genes & Cancer · doi:10.1177/1947601912455199 · Cited by 214 · see citing works
Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2
Ferreon, J. C., Lee, C. W., Arai, M., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811023106 · Cited by 210 · see citing works
The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73
Levy, D., Adamovich, Y., Reuven, N. B., & Shaul, Y. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402063 · Cited by 210 · see citing works
Complicating the complexity of p53
Yee, K. S. Y., & Vousden, K. H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi122 · Cited by 187 · see citing works
Brooks, C. L., & Gu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.022 · Cited by 186 · see citing works
hCAS/CSE1L Associates with Chromatin and Regulates Expression of Select p53 Target Genes
Tanaka, T., Ohkubo, S., Tatsuno, I., & Prives, C. L. (2007) · Cell · doi:10.1016/j.cell.2007.08.001 · Cited by 171 · see citing works
BBAP Monoubiquitylates Histone H4 at Lysine 91 and Selectively Modulates the DNA Damage Response
Yan, Q., Dutt, S., Xu, R., Graves, K., Juszczyński, P., Manis, J. P., & Shipp, M. A. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.019 · Cited by 165 · see citing works
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis
Lee, E., Lee, M.-S., Camus, S., Ghim, J., Yang, M. R., Oh, W., Ha, N., Lane, D. P., & Song, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.164 · Cited by 158 · see citing works
Ubiquitin‐specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor
Maertens, G. N., Messaoudi, S. E., Elderkin, S., Hiom, K. J., & Peters, G. G. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.129 · Cited by 155 · see citing works
Chao, C. C. ‐. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.015 · Cited by 152 · see citing works
MOZ increases p53 acetylation and premature senescence through its complex formation with PML
Rokudai, S., Laptenko, O., Arnal, S. M., Taya, Y., Kitabayashi, I., & Prives, C. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300490110 · Cited by 155 · see citing works
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
Wang, W., Albadari, N. G., Du, Y., Fowler, J. F., Sang, H. T., Xian, W., McKeon, F., Li, W., Zhou, J., & Zhang, R. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001026 · Cited by 147 · see citing works
Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway
Zhang, Z., Wang, H., Li, M., Rayburn, E. R., Agrawal, S., & Zhang, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208814 · Cited by 139 · see citing works
Daou, S., Hammond-Martel, I., Mashtalir, N., Barbour, H., Gagnon, J. K., Iannantuono, N., Nkwe, N. S., Motorina, A., Pak, H., Yu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661553 · Cited by 136 · see citing works
Writing and reading H2B monoubiquitylation
Fuchs, G., & Oren, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.01.002 · Cited by 135 · see citing works
Self-citationHistone H2B monoubiquitination: roles to play in human malignancy
Cole, A. J., Clifton-Bligh, R. J., & Marsh, D. J. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0185 · Cited by 129 · see citing works
New insights into p53 activation
Brooks, C. L., & Gu, W. J. (2010) · Cell Research · doi:10.1038/cr.2010.53 · Cited by 127 · see citing works
MDM2 and MDMX: Alone and together in regulation of p53.
Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 125 · see citing works
Deng, Z., Cao, P. D., Wan, M., & Sui, G. (2010) · Transcription · doi:10.4161/trns.1.2.12375 · Cited by 125 · see citing works
Arva, N. C., Gopen, T., Talbott, K. E., Campbell, L. E., Chicas, A., White, D. E., Bond, G. L., Levine, A. J., & Bargonetti, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505203200 · Cited by 122 · see citing works
Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis
Grinkevich, V. V., Nikulenkov, F., Shi, Y., Enge, M., Bao, W., Malyukova, A., Gluch, A., Kel, A. E., Sangfelt, O., & Selivanova, G. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.021 · Cited by 118 · see citing works
Sarkari, F., Sanchez-Alcaraz, T., Wang, S., Holowaty, M. N., Sheng, Y., & Frappier, L. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000624 · Cited by 115 · see citing works
Wienken, M., Dickmanns, A., Nemajerová, A., Kramer, D., Najafova, Z., Weiss, M., Karpiuk, O., Kassem, M. S., Zhang, Y., Lozano, G., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.12.008 · Cited by 109 · see citing works
Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53
Arena, G., Cissé, M. Y., Pyrdziak, S., Châtre, L., Riscal, R., Fuentes, M., Arnold, J. J., Kastner, M., Gayte, L., Bertrand‐Gaday, C., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.023 · Cited by 109 · see citing works
Meisetz and the birth of the KRAB motif
Birtle, Z. E., & Ponting, C. P. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl498 · Cited by 105 · see citing works
Targeting epigenetic enzymes for drug discovery
Copeland, R. A., Olhava, E. J., & Scott, M. P. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.174 · Cited by 103 · see citing works
Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway
Busso, C. S., Iwakuma, T., & Izumi, T. (2009) · Oncogene · doi:10.1038/onc.2009.5 · Cited by 100 · see citing works
Shema, E., Kim, J., Roeder, R. G., & Oren, M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.011 · Cited by 102 · see citing works
Self-citationRegulation of the p53 transcriptional activity
Liu, G., & Chen, X. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20700 · Cited by 99 · see citing works
Aylon, Y., Ofir-Rosenfeld, Y., Yabuta, N., Lapi, E., Nojima, H., Lü, X., & Oren, M. (2010) · Genes & Development · doi:10.1101/gad.1954410 · Cited by 100 · see citing works
Self-citationFåhræus, R., & Olivares‐Illana, V. (2013) · Oncogene · doi:10.1038/onc.2013.410 · Cited by 97 · see citing works
Shema, E., Nikolov, M., Haj‐Yahya, M., Siman, P., Allemand, E., Yamaguchi, Y., Muchardt, C., Urlaub, H., Brik, A., Oren, M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.014 · Cited by 93 · see citing works
Self-citationCooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing
Wu, X., Gong, Y., Yue, J., Qiang, B., Yuan, J., & Peng, X. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn243 · Cited by 92 · see citing works
The enigmatic role of H2Bub1 in cancer
Johnsen, S. A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.002 · Cited by 90 · see citing works
RYBP stabilizes p53 by modulating MDM2
Chen, D., Zhang, J., Li, M., Rayburn, E. R., Wang, H., & Zhang, R. (2008) · EMBO Reports · doi:10.1038/embor.2008.231 · Cited by 89 · see citing works
Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer
Jeusset, L. M., & McManus, K. J. (2019) · Cells · doi:10.3390/cells8020165 · Cited by 88 · see citing works
Muench, P., Probst, S., Schuetz, J., Leiprecht, N., Busch, M., Wesselborg, S., Stubenrauch, F., & Iftner, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1307 · Cited by 89 · see citing works
Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 87 · see citing works
Tyteca, S., Vandromme, M., Legube, G., Chevillard, M., & Trouche, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601066 · Cited by 86 · see citing works
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
Brekman, A., Singh, K. E., Polotskaia, A., Kundu, N., & Bargonetti, J. (2011) · Breast Cancer Research · doi:10.1186/bcr2804 · Cited by 71 · see citing works
Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-Myc
Dai, M., Jin, Y., Gallegos, J. R., & Lu, H. (2006) · Neoplasia · doi:10.1593/neo.06334 · Cited by 83 · see citing works
Menendez, D., Inga, A., & Resnick, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2297-2308.2006 · Cited by 81 · see citing works
Ubiquitin–Proteasome System in Spermatogenesis
Bose, R., Manku, G., Culty, M., & Wing, S. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0817-2_9 · Cited by 79 · see citing works
RNA content in the nucleolus alters p53 acetylation via MYBBP1A
Kuroda, T., Murayama, A., Katagiri, N., Ohta, Y., Fujita, E., Masumoto, H., Ema, M., Takahashi, S., Kimura, K., & Yanagisawa, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.23 · Cited by 73 · see citing works
Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
Nomura, K., Klejnot, M., Kowalczyk, D., Hock, A. K., Sibbet, G. J., Vousden, K. H., & Huang, D. T. C. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3414 · Cited by 72 · see citing works
Aylon, Y., Yabuta, N., Besserglick, H., Buganim, Y., Rotter, V., Nojima, H., & Oren, M. (2009) · Oncogene · doi:10.1038/onc.2009.270 · Cited by 71 · see citing works
Self-citationBiochemical and Biophysical Characterization of a Chimeric TRIM21-TRIM5α Protein
Kar, A. K., Diaz‐Griffero, F., Li, Y., Li, X., & Sodroski, J. (2008) · Journal of Virology · doi:10.1128/jvi.01559-08 · Cited by 70 · see citing works
E3 Ligases Determine Ubiquitination Site and Conjugate Type by Enforcing Specificity on E2 Enzymes
David, Y., Ternette, N., Edelmann, M. J., Ziv, T., Gayer, B., Sertchook, R., Dadon, Y., Kessler, B. M., & Navon, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234559 · Cited by 69 · see citing works
Song, J., Ma, S., Luo, J., Zhang, H., Wang, R.-X., Liu, H., Li, L., Zhang, Z., & Zhou, R. (2018) · Oncology Reports · doi:10.3892/or.2018.6282 · Cited by 69 · see citing works
Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14ARF-MDM2-p53 axis
Maerken, T. V., Vandesompele, J., Rihani, A., Paepe, A. D., & Speleman, F. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.138 · Cited by 70 · see citing works
Histone Ubiquitylation and the Regulation of Transcription
Osley, M. A., Fleming, A. B., & Kao, C.-F. (2006) · Results and problems in cell differentiation · doi:10.1007/400_006 · Cited by 66 · see citing works
KE, Q., Ellen, T. P., & Costa, M. W. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.12.015 · Cited by 65 · see citing works
Jäger, W., Santag, S., Weidner-Glunde, M., Gellermann, E., Kati, S., Pietrek, M., Viejo‐Borbolla, A., & Schulz, T. F. (2012) · Journal of Virology · doi:10.1128/jvi.06840-11 · Cited by 65 · see citing works
Histone H2B ubiquitination: the cancer connectionPreprint
Espinosa, J. M. (2008) · Genes & Development · doi:10.1101/gad.1732108 · Cited by 65 · see citing works
Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication
Klusmann, I., Wohlberedt, K., Magerhans, A., Teloni, F., Korbel, J. O., Altmeyer, M., & Dobbelstein, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809592115 · Cited by 62 · see citing works
MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output
Chen, L., Li, Z., Zwolińska, A., Smith, M. A., Cross, B. L., Koomen, J. M., Yuan, Z.-M., Jenuwein, T., Marine, J., Wright, K. L., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.140 · Cited by 61 · see citing works
Histone monoubiquitination by Clock-Bmal1 complex marks Per1 and Per2 genes for circadian feedback
Tamayo, A. G., Duong, H. A., Robles, M. S., Mann, M., & Weitz, C. J. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3076 · Cited by 60 · see citing works
Mdm2 in growth signaling and cancer
Levav-Cohen, Y., Haupt, S., & Haupt, Y. (2005) · Growth Factors · doi:10.1080/08977190500196218 · Cited by 60 · see citing works
The p53-mediated cytotoxicity of photodynamic therapy of cancer: Recent advances
Zawacka‐Pankau, J., Krachulec, J., Grulkowski, I., Bielawski, K. P., & Selivanova, G. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.07.012 · Cited by 59 · see citing works
RNA-binding E3 ubiquitin ligases: novel players in nucleic acid regulation
Cano, F., Miranda‐Saavedra, D., & Lehner, P. J. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381621 · Cited by 55 · see citing works
Yan, B., Yang, X., Lee, T., Friedman, J., Tang, J., Waes, C. V., & Chen, Z. (2007) · Genome biology · doi:10.1186/gb-2007-8-5-r78 · Cited by 56 · see citing works
Mdm2 and MdmX as Regulators of Gene Expression
Biderman, L., Manley, J. L., & Prives, C. L. (2012) · Genes & Cancer · doi:10.1177/1947601912455331 · Cited by 55 · see citing works
Mungamuri, S. K., Qiao, R. F., Yao, S., Manfredi, J. J., Gu, W., & Aaronson, S. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.049 · Cited by 54 · see citing works
Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1
Sun, X. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.75 · Cited by 55 · see citing works
Histone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer
Marsh, D. J., Ma, Y., & Dickson, K.-A. (2020) · Cancers · doi:10.3390/cancers12113462 · Cited by 53 · see citing works
Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy
Allende-Vega, N., & Saville, M. K. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.004 · Cited by 51 · see citing works
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Li, M., & Gu, W. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.020 · Cited by 50 · see citing works
Targeting the MDM2/MDM4 Interaction Interface as a Promising Approach for p53 Reactivation Therapy
Pellegrino, M., Mancini, F., Lucà, R., Coletti, A., Giacchè, N., Manni, I., Arisi, I., Florenzano, F., Teveroni, E., Buttarelli, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0439 · Cited by 48 · see citing works
Mechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation
Brooks, C. L., Li, M., & Gu, W. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700961200 · Cited by 48 · see citing works
Ohkubo, S., Tanaka, T., Taya, Y., Kitazato, K., & Prives, C. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601388200 · Cited by 47 · see citing works
Control of Cell Proliferation and Growth by Myc Proteins
Bernard, S., & Eilers, M. (2006) · Springer eBooks · doi:10.1007/400_004 · Cited by 47 · see citing works
Wienken, M., Moll, U. M., & Dobbelstein, M. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw046 · Cited by 44 · see citing works
Writing Histone Monoubiquitination in Human Malignancy—The Role of RING Finger E3 Ubiquitin Ligases
Marsh, D. J., & Dickson, K.-A. (2019) · Genes · doi:10.3390/genes10010067 · Cited by 43 · see citing works
Yu, Z.-C., Huang, Y., & Shieh, S.-Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1173 · Cited by 44 · see citing works
Wilkinson, D. S., Tsai, W.-W., Schumacher, M. A., & Barton, M. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01442-07 · Cited by 44 · see citing works
USP7/HAUSP stimulates repair of oxidative DNA lesions
Khoronenkova, S. V., Dianova, I. I., Parsons, J. L., & Dianov, G. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1210 · Cited by 40 · see citing works
MDM2 and MDMX in Cancer and Development
Marine, J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00003-6 · Cited by 38 · see citing works
Epigenetic modification and a role for the E3 ligase RNF40 in cancer development and metastasis
Fu, J., Liao, L., Balaji, K. S., Wei, C., Kim, J., & Peng, J. (2020) · Oncogene · doi:10.1038/s41388-020-01556-w · Cited by 37 · see citing works
MEL-18 loss mediates estrogen receptor–α downregulation and hormone independence
Lee, J., Won, H., Park, J., Kim, H., Choi, H., Shin, D., Kang, J., Woo, J. K., Oh, S.-H., Son, T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73743 · Cited by 36 · see citing works
Splicing Up Mdm2 for Cancer Proteome Diversity
Okoro, D. R., Rosso, M., & Bargonetti, J. (2012) · Genes & Cancer · doi:10.1177/1947601912455323 · Cited by 36 · see citing works
- Authors
- Minsky, N., & Oren, M.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Oren, Moshe
- ORCID
- Oren, Moshe
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 16
- Issue
- 4
- Pages
- 631-639
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W1999310200
- Cited by
- 204
- References
- 54
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 8 · 2019: 13 · 2018: 6 · 2017: 1 · 2016: 7 · 2015: 13 · 2014: 10 · 2013: 5 · 2012: 12
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R37 CA40099, R37CA040099)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- MDM2, RING domain, E3 ubiquitin ligase, histone ubiquitination, histone H2A, transcriptional repression, p53, chromatin, gene silencing, oncogenic activity
- MeSH terms
- Cell Line, Chromatin, Glutathione Transferase, Histones, Humans, Luciferases, Nuclear Proteins, Precipitin Tests, Promoter Regions, Genetic, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transcription, Genetic, Ubiquitins, Gene Expression Regulation, Neoplastic, Genes, Reporter, Cell Line, Tumor, Chromatin Immunoprecipitation, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review